Gene · 3853
Papers1,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 36725337 | PubTator, text mining | PubMed |
| Nanofiber Aerogels with Precision Macrochannels and LL-37-Mimic Peptides Synergistically Promote Diabetic Wound Healing. | Adv Funct Mater | 2023 | 36714167 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. | Signal Transduct Target Ther | 2023 | 36710358 | PubTator, text mining | PubMed |
| Total Hip Arthroplasty in the Setting of Post-Traumatic Arthritis Following Acetabular Fracture: A Systematic Review. | Arthroplast Today | 2023 | 36691464 | PubTator, text mining | PubMed |
| A subnetwork-based framework for prioritizing and evaluating prognostic gene modules from cancer transcriptome data. | iScience | 2023 | 36685033 | PubTator, text mining | PubMed |
| Inhibiting EGFR Signaling Holds Promise for Treating Palmoplantar Keratodermas. | J Invest Dermatol | 2023 | 36681421 | PubTator, text mining | PubMed |
| New Data on the Features of Skin Barrier in Hidradenitis Suppurativa. | Biomedicines | 2023 | 36672635 | PubTator, text mining | PubMed |
| Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression. | Biomolecules | 2023 | 36671512 | PubTator, text mining | PubMed |
| The Therapeutic Alliance between Pomegranate and Health Emphasizing on Anticancer Properties. | Antioxidants (Basel) | 2023 | 36671048 | PubTator, text mining | PubMed |
| Phenotype and genotype features of Vietnamese children with pachyonychia congenita. | Pediatr Neonatol | 2023 | 36658016 | PubTator, text mining | PubMed |
| Vision transformer-based weakly supervised histopathological image analysis of primary brain tumors. | iScience | 2023 | 36647383 | PubTator, text mining | PubMed |
| Analysis of transcriptional changes in the immune system associated with pubertal development in a longitudinal cohort of children with asthma. | Nat Commun | 2023 | 36646693 | PubTator, text mining | PubMed |
| KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer. | Cancer Res | 2023 | 36638328 | PubTator, text mining | PubMed |
| CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer. | Cancer Immunol Res | 2023 | 36633583 | PubTator, text mining | PubMed |
| Water-soluble extracellular vesicle probes based on conjugated oligoelectrolytes. | Sci Adv | 2023 | 36630497 | PubTator, text mining | PubMed |
| Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma. | Int J Mol Sci | 2023 | 36614248 | PubTator, text mining | PubMed |
| Role of NF-κB in lead exposure-induced activation of astrocytes based on bioinformatics analysis of hippocampal proteomics. | Chem Biol Interact | 2023 | 36539177 | PubTator, text mining | PubMed |
| Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm. | Biochim Biophys Acta Rev Cancer | 2023 | 36535512 | PubTator, text mining | PubMed |
| Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 36484700 | PubTator, text mining | PubMed |
| Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes. | Clin Transl Oncol | 2023 | 36447119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3853/papers?page=17